Table 4.
Variables | 5‐year local control rate (%) | P‐value |
---|---|---|
Age at RT, years | 0.906 | |
<70 | 79% | |
≥70 | 81% | |
Patient sex | 0.149 | |
Female | 71% | |
Male | 100% | |
Histology | 0.615 | |
SCC | 77% | |
Other | 86% | |
Chemotherapy | 0.142 | |
No | 68% | |
Yes | 89% | |
RT type | 0.715 | |
Proton | 81% | |
Photon | 75% | |
RT fractionation | 0.286 | |
Standard fractionation | 74% | |
SBRT | 100% | |
IgG response | 0.921 | |
Absent | 79% | |
Present | 83% | |
IgM response | 0.340 | |
Absent | 89% | |
Present | 71% | |
IgG or IgM response | 0.699 | |
Absent | 83% | |
Present | 77% |
RT, radiation therapy; SBRT, stereotactic body radiation therapy; SCC, squamous cell carcinoma.